Barclays Maintains Overweight on Marex Group, Lowers Price Target to $49

Benzinga · 01/08 21:08
Barclays analyst Benjamin Budish maintains Marex Group (NASDAQ:MRX) with a Overweight and lowers the price target from $50 to $49.